Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Dexcom (DXCM) over the last 15 years, with Q4 2025 value amounting to $45.8 million.

  • Dexcom's Other Accumulated Expenses rose 2345.01% to $45.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $45.8 million, marking a year-over-year increase of 2345.01%. This contributed to the annual value of $45.8 million for FY2025, which is 2345.01% up from last year.
  • Latest data reveals that Dexcom reported Other Accumulated Expenses of $45.8 million as of Q4 2025, which was up 2345.01% from $42.0 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Other Accumulated Expenses registered a high of $62.9 million during Q1 2022, and its lowest value of $36.7 million during Q3 2024.
  • Over the past 5 years, Dexcom's median Other Accumulated Expenses value was $46.1 million (recorded in 2024), while the average stood at $45.7 million.
  • In the last 5 years, Dexcom's Other Accumulated Expenses soared by 6928.33% in 2021 and then crashed by 2728.94% in 2022.
  • Over the past 5 years, Dexcom's Other Accumulated Expenses (Quarter) stood at $54.6 million in 2021, then fell by 27.29% to $39.7 million in 2022, then grew by 2.02% to $40.5 million in 2023, then fell by 8.4% to $37.1 million in 2024, then grew by 23.45% to $45.8 million in 2025.
  • Its Other Accumulated Expenses stands at $45.8 million for Q4 2025, versus $42.0 million for Q3 2025 and $42.6 million for Q2 2025.